Palomino Laboratories Cash Flow Statement (2023-2025) | PALX

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income (Quarter) -0.04M-0.03M-0.05M-0.03M116.00-0.14M-0.06M-0.04M-1.60M
Share-based Compensation (Quarter) 1.26M
Gains from Sales and Divestitures (Quarter) 0.37M
Gains from Investment Securities (Quarter) 1.50M0.73M
Cash from Operations (Quarter) -0.06M0.03M-0.17M-0.01M-0.04M-0.34M
Change in Working Capital
Change in Account Payables (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M-0.01M-0.03M0.00M0.00M0.05M
Change in Accured Expenses (Quarter) -0.03M0.05M-0.00M0.00M-0.04M0.04M-0.01M0.46M
Other Working Capital Changes (Quarter) -0.00M
Financing Activities
Cash from Financing Activities (Quarter) 0.06M0.02M0.14M8.13M
Additional items
Change in Cash (Quarter) 888.000.03M-0.01M-0.02M7.79M
Free Cash Flow (Quarter) -0.06M0.03M-0.17M-0.01M-0.04M-0.34M
Net Cash Flow (Quarter) 0.05M-0.02M-0.01M-0.04M7.79M